Penumbra (PEN) Total Liabilities (2014 - 2026)
Penumbra (PEN) posted quarterly Total Liabilities of $444.0 million for Q2 2026, up 16.57% year-over-year from $380.9 million in Q2 2025, and up 4.55% quarter-over-quarter from $424.6 million in Q1 2026.
Penumbra (PEN) Total Liabilities (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Total Liabilities for 13 consecutive years, with $444.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities rose 16.57% year-over-year to $444.0 million; the TTM figure through Jun 2026 stood at $444.0 million (up 16.57% YoY), while the FY2025 annual figure was $398.9 million, up 4.36% from the prior year.
- Total Liabilities climbed to $444.0 million in Q2 2026 per PEN's latest filing, from $424.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $444.0 million in Q2 2026 and bottomed at $342.3 million in Q1 2022.
- Historically, Total Liabilities has averaged $378.9 million across 5 years, with a median of $375.6 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 79.81% — and 2025, when it increased 1.09%.
- Penumbra's Total Liabilities stood at $372.0 million in 2022, then grew by 1.43% to $377.4 million in 2023, then rose by 1.3% to $382.2 million in 2024, then gained by 4.36% to $398.9 million in 2025, then increased by 11.29% to $444.0 million in 2026.
- Business Quant data shows PEN's Total Liabilities at $444.0 million in Q2 2026, $424.6 million in Q1 2026, and $398.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 443.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 443.96 Mn |
| Mar 31, 2026 | 424.63 Mn |
| Dec 31, 2025 | 398.92 Mn |
| Sep 30, 2025 | 385.67 Mn |
| Jun 30, 2025 | 380.86 Mn |
| Mar 31, 2025 | 380.43 Mn |
| Dec 31, 2024 | 382.25 Mn |
| Sep 30, 2024 | 374.84 Mn |
| Jun 30, 2024 | 373.33 Mn |
| Mar 31, 2024 | 376.31 Mn |
| Dec 31, 2023 | 377.36 Mn |
| Sep 30, 2023 | 364.24 Mn |
| Jun 30, 2023 | 365.99 Mn |
| Mar 31, 2023 | 370.83 Mn |
| Dec 31, 2022 | 372.03 Mn |
| Sep 30, 2022 | 347.85 Mn |
| Jun 30, 2022 | 357.89 Mn |
| Mar 31, 2022 | 342.27 Mn |
| Dec 31, 2021 | 290.32 Mn |
| Sep 30, 2021 | 288.64 Mn |